Analysis
The International Prostate Symptom Score (IPSS) is a widely used diagnostic tool for evaluating symptoms related to benign prostatic hyperplasia (BPH). The scale assesses the severity of symptoms and their impact on the patient’s quality of life. It is frequently used in clinical practice to aid in diagnosis, monitor disease progression, and evaluate the effectiveness of therapeutic interventions.
Objective
The aim of the scale is:
Symptom Assessment: To measure the severity and frequency of BPH symptoms such as frequency, nocturia, and difficulty initiating urination.
Understanding the Impact on Quality of Life: To assess the effect of symptoms on daily life and the patient’s quality of life.
Support of the Diagnostic Process: To assist in the diagnosis of BPH and in monitoring the progression of symptoms.
Evaluation of Therapeutic Interventions: To support the assessment of the effectiveness of therapeutic interventions in improving symptoms and quality of life.
Scoring
The scale consists of seven questions about symptoms and one question about quality of life. The symptom questions are rated from 0 (never) to 5 (almost always). Total scores range from 0 to 35, with higher scores indicating more severe symptoms. The quality of life question is scored from 0 (delighted) to 6 (terrible).
References
Barry, M. J., Fowler, F. J., O’Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., & Mebust, W. K. (1992). The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. The Journal of Urology, 148(5), 1549–1557.
Roehrborn, C. G. (2005). Benign Prostatic Hyperplasia: An Overview. Reviews in Urology, 7(9), S3–S14.
Chapple, C. R. (2006). Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Triumph: Design and Implementation. European Urology, 49(4), 491–502.
Kirby, R. S., Lepor, H., & Fitzpatrick, J. M. (2009). Textbook of Benign Prostatic Hyperplasia. Informa Healthcare.
McVary, K. T. (2006). BPH: Epidemiology and Comorbidities. American Journal of Managed Care, 12(4 Suppl), S122–S128.